Phase 2 Clinical Trial to Confirm the Dose and Formulation of a Recombinant Quadrivalent Nanoparticle Influenza Vaccine (Quad-NIV) With or Without Matrix-M1™ Adjuvant in Healthy Adults ≥ 65 Years of Age
Phase: PHASE2
Conditions: Influenza, Human
Sponsor: Novavax



Powered by TCPDF (www.tcpdf.org)
Powered by TCPDF (www.tcpdf.org)
Powered by TCPDF (www.tcpdf.org)
Powered by TCPDF (www.tcpdf.org)
Powered by TCPDF (www.tcpdf.org)
Powered by TCPDF (www.tcpdf.org)
Powered by TCPDF (www.tcpdf.org)
Powered by TCPDF (www.tcpdf.org)
Powered by TCPDF (www.tcpdf.org)
Powered by TCPDF (www.tcpdf.org)
Powered by TCPDF (www.tcpdf.org)